NEW YORK, NY / ACCESSWIRE / August 17, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/staa.
The investigation concerns whether STAAR and certain of its officers and/or directors have violated federal securities laws.
On August 11, 2020, research firm J Capital published a report that called into question STAAR's representations with respect to its purported success in the Chinese market, accusing the Company of overstating its sales in China by at least one-third (or $21.6 million). Citing over 75 interviews with former employees, site visits to China and Switzerland, and an extensive review of public documents, the J Capital report asserted that STAAR has reported fake sales revenues by overstating sales and then marking up actual marketing costs to hide "phantom" revenue. On this news, STAAR's stock price fell $3.17 per share, or 6.16%, to close at $48.25 per share on August 11, 2020.
If you are aware of any facts relating to this investigation, or purchased STAAR shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/staa. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz and Grossman, LLC